SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Revance Posts Quarterly Loss Per Share Of $1.08

05/10/2021 18:18
BRIEF-Revance Posts Quarterly Loss Per Share Of $1.08

- Revance Therapeutics Inc RVNC.O:

  • REVANCE REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE

  • REITERATES ITS FINANCIAL GUIDANCE PROVIDED IN FEBRUARY 2021

  • Q1 REVENUE $13.3 MILLION

  • QTRLY LOSS PER SHARE $1.08

  • REVANCE THERAPEUTICS - AS OF DATE OF EARNINGS RELEASE, FDA HAS NOT SCHEDULED OR CONDUCTED PRE-APPROVAL INSPECTION OF CO'S NORTHERN CALIFORNIA FACILITY

Source text for Eikon: ID:nBw5n4BZwa

Further company coverage: RVNC.O


(([email protected];))